Cargando…

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

The importance of the kynurenine pathway in normal immune system function has led to an appreciation of its possible contribution to autoimmune disorders such as rheumatoid arthritis. Indoleamine-2,3-dioxygenase (IDO) activity exerts a protective function, limiting the severity of experimental arthr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yi-Shu, Ogbechi, Joy, Clanchy, Felix I., Williams, Richard O., Stone, Trevor W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066259/ https://www.ncbi.nlm.nih.gov/pubmed/32194572 http://dx.doi.org/10.3389/fimmu.2020.00388

Ejemplares similares

Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
por: Clanchy, Felix I. L., et al.
Publicado: (2022)

Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
por: Ogbechi, Joy, et al.
Publicado: (2022)

An integrated cytokine and kynurenine network as the basis of neuroimmune communication
por: Stone, Trevor W., et al.
Publicado: (2022)

Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
por: Stone, Trevor W., et al.
Publicado: (2023)

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
por: Zhao, Li-Ping, et al.
Publicado: (2023)

Editorial: Multiple Implications of the Kynurenine Pathway in Inflammatory Diseases: Diagnostic and Therapeutic Applications
por: Mándi, Yvette, et al.
Publicado: (2022)

IDO/kynurenine pathway in cancer: possible therapeutic approaches
por: Abd El-Fattah, Eslam E.
Publicado: (2022)

Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease
por: Gáspár, Renáta, et al.
Publicado: (2022)

Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review
por: Fathi, Mobina, et al.
Publicado: (2022)

Impact of IDO1 and IDO2 on the B Cell Immune Response
por: Merlo, Lauren M. F., et al.
Publicado: (2022)

IDO2 in Immunomodulation and Autoimmune Disease
por: Prendergast, George C., et al.
Publicado: (2014)

Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
por: Skorobogatov, Katrien, et al.
Publicado: (2021)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses
por: Merlo, Lauren M. F., et al.
Publicado: (2020)

Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
por: Triplett, Todd A., et al.
Publicado: (2018)

Psychological Stresses in Children Trigger Cytokine- and Kynurenine Metabolite-Mediated Abdominal Pain and Proinflammatory Changes
por: Myint, Kyaimon, et al.
Publicado: (2021)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
por: Napolioni, Valerio, et al.
Publicado: (2019)

Kynurenines in CNS disease: regulation by inflammatory cytokines
por: Campbell, Brian M., et al.
Publicado: (2014)

The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
por: Anu, R. I., et al.
Publicado: (2023)

Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD(+) Synthesis During Inflammation and Infection
por: Moffett, John R., et al.
Publicado: (2020)

Immunological Relevance of the Coevolution of IDO1 and AHR
por: Jaronen, Merja, et al.
Publicado: (2014)

IDO Targeting in Sarcoma: Biological and Clinical Implications
por: Nafia, Imane, et al.
Publicado: (2020)

Kynurenine pathway metabolites in migraine
por: Nicoletti, Ferdinando
Publicado: (2015)

Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
por: Torosyan, Rafael, et al.
Publicado: (2021)

The kynurenine pathway in HIV, frailty and inflammaging
por: Sultana, Shabiha, et al.
Publicado: (2023)

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
por: Mithaiwala, Mustafa N., et al.
Publicado: (2021)

Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: A systematic Review and meta-analysis
por: Fathi, Mobina, et al.
Publicado: (2022)

New Insights into IDO Biology in Bacterial and Viral Infections
por: Schmidt, Susanne V., et al.
Publicado: (2014)

On the Non-Redundant Roles of TDO2 and IDO1
por: Puccetti, Paolo
Publicado: (2014)

Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
por: Wainwright, Derek A., et al.
Publicado: (2013)

IDO Expression in Cancer: Different Compartment, Different Functionality?
por: Meireson, Annabel, et al.
Publicado: (2020)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
por: Mondanelli, Giada, et al.
Publicado: (2021)

Standardization of Antigen-Emulsion Preparations for the Induction of Autoimmune Disease Models
por: Topping, Louise M., et al.
Publicado: (2022)

IDO-GCN2 and autophagy in inflammation
por: McGaha, Tracy L.
Publicado: (2015)

The roles of fungus in CNS autoimmune and neurodegeneration disorders
por: Wu, Chuyu, et al.
Publicado: (2023)

Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015)

An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases
por: Bo, Li, et al.
Publicado: (2018)

Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma
por: Meireson, Annabel, et al.
Publicado: (2021)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
por: Boros, Fanni A., et al.
Publicado: (2019)

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine
por: Tian, Chang-Qing, et al.
Publicado: (2019)

Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production
por: Bellucci, Michele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0m5mieothis8qlhd020a636p18